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Abstract 
This study evaluated the biological correlates and psychometrics of the Biber Figure 
Learning Test (BFLT), a visuospatial serial figure learning test, for use in detecting 
cognitive impairment in older adults. Non-demented individuals (n=322, 72±7, 41% 
female) from the Vanderbilt Memory & Aging Project completed a comprehensive 
neuropsychological protocol. Adjusted regression models related BFLT indices to 
structural brain MRI and cerebrospinal fluid markers (CSF) of brain health. 
Psychometric properties were examined, including construct validity and regression-
based normative data. Lower BFLT performance related to smaller medial temporal 
lobe volumes and higher CSF tau concentrations. BFLT indices were most strongly 
correlated with other measures of verbal and non-verbal memory measures and 
executive functioning. The BFLT comprehensively assesses all aspects of visuospatial 
learning and memory and is sensitive to markers of unhealthy brain aging. Enhanced 
normative data enriches the clinical utility of this visual serial figure-learning test for use 
with older adults.  
 
Key words: episodic memory, visual memory, normative data, aging, regression-based 
norms  
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Introduction 
Alzheimer’s disease (AD) is a major public health issue, and early diagnosis is 
critical to managing disease burden. As such, neuropsychological assessment, 
specifically episodic learning and memory, is an integral component for early and 
accurate diagnosis of AD (Karantzoulis & Galvin, 2011). Clinically, AD is often 
characterized by an insidious decline in episodic memory, particularly in the early 
phases of illness. Serial verbal list-learning tests (e.g., Brandt, 2001;  Delis, Kramer, 
Kaplan, & Ober, 2000) have demonstrated great utility in early detection of AD because 
they assess key constructs underlying memory and learning, including encoding or rate 
of acquisition, retrieval, and susceptibility to proactive and retroactive interference 
(Albert et al., 2011). Examples of such verbal supraspan tests include the California 
Verbal Learning Test-Second Edition (CVLT-II; Delis et al., 2000), the Rey Auditory 
Verbal Learning Test (Tierney et al., 1994), and the Hopkins Verbal Learning Test-
Revised (Brandt, 2001).  
Surprisingly, a non-verbal analogue to these verbal list-learning tests is lacking 
given the number of commonly used tools to assess aspects of visual encoding, 
retrieval, and memory. While each measure is valuable in assessing some aspects of 
visual learning and memory, no single tool reflects the full range of episodic memory 
constructs that are essential to define in clinical practice. For example, common visual 
measures, such as Rey-Osterrieth Complex Figure Test (Osterrieth, 1944; Rey, 1941), 
WMS Visual Reproduction (Wechsler, 2009), or Benton Visual Retention Test (BVRT; 
Sivan, 1992), assess memory using a single exposure or learning trial, limiting 
measurement of learning (acquisition). While tests such as the Brief Visuospatial 
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Memory Test-Revised (Benedict, Schretlen, Groninger, Dobraski, & Shpritz, 1996) and 
the Visual Spatial Learning Test (Malec, Ivnik, & Hinkeldey, 1991) include presentation 
of material over several learning trials, neither tool assesses vulnerability to proactive or 
retroactive interference through introduction of a distractor trial. Thus, while several 
visual learning and memory tools are available for clinical implementation, their varied 
methodologies limit more detailed assessment of well-known constructs underlying 
episodic memory, including encoding, retrieval, recognition, and susceptibility to 
interference. Further, the existing paradigms preclude direct comparison with existing 
verbal supraspan tests.  
The Biber Figure Learning Test (BFLT) is a visuospatial serial figure learning test 
designed to assess key components underlying episodic memory (Glosser, Goodglass, 
& Biber, 1989). It was modelled after supraspan tests (Delis, Kramer, Kaplan, & Ober, 
1987; Delis et al., 2000) and Rey’s visuospatial task (Rey, 1968), and was originally 
developed as a 10-item memory test (Glosser et al., 1989). The BFLT (extended; 
Glosser, Cole, Khatri, DellaPietra, & Kaplan, 2002) is comprised of five immediate free 
recall learning trials of 15 non-familiar geometric shapes of moderate visual complexity, 
an interference condition that presents a new list of 15 items (Distractor Trial), short and 
long delay free recall trials for the original 15 items, and a recognition trial that includes 
the original items, interference items, and new test items.  
The BFLT offers several advantages over other available visual memory tools. 
First, it is a visuospatial analogue to verbal list-learning tasks with indices capturing 
encoding/rate of acquisition, retrieval, susceptibility to proactive and retroactive 
interference, and recognition test performance. Thus, when used together, both tools 
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provide parallel information to inform the potential presence of modality-specific memory 
impairment. Second, the BFLT has an alternate test form for repeat administration 
needs. Third, the BFLT includes an abbreviated 10-item version to accommodate 
patients suspected of more compromised neuropsychological function, such as 
dementia (Glosser et al., 2002; Glosser et al., 1989). Collectively, the BFLT provides an 
opportunity to comprehensively assess specific visual episodic modalities using a 
format consistent with a verbal serial list-learning paradigm, making the BFLT potentially 
more useful than many widely used visual memory tools. 
Despite the BFLT’s potential clinical utility, the test has not been widely used. 
Foremost, the validity of this visuospatial memory test is not well delineated. 
Establishing a link between BFLT indices and markers of unhealthy brain aging, 
including AD, such as amyloid, neurodegeneration, and white matter disease is 
essential to demonstrating the utility and validity of this test in older adult populations. 
Existing BFLT data have been restricted to individuals with epilepsy or non-AD amnestic 
syndromes implicating medial temporal lobe and subcortical-limbic pathways (Glosser 
et al., 1989), particularly within the right hemisphere (Glosser et al., 2002). Similarly, 
establishing evidence of convergent and discriminant validity with other 
neuropsychological measures is needed. Second, there is a lack of comprehensive 
normative data; existing normative data is restricted to a few dozen individuals and 
upper age bands (e.g., 40 to 79 years; Glosser et al., 1989) with minimal consideration 
of how important demographic variables, such as age, sex, education, and 
race/ethnicity (Norman, Evans, Miller, & Heaton, 2000) may confound performance.  
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Leveraging a community-based sample, this study has several objectives. First, 
we aim to examine the biological correlates of the BFLT, hypothesizing that BFLT 
indices would relate to markers of unhealthy brain aging including amyloid pathology 
(cerebrospinal fluid (CSF) amyloid beta42; Mandecka et al., 2016), neurodegeneration 
(hippocampal volume on brain MRI, inferior lateral ventricle volume on brain MRI, and 
CSF tau; Mandecka et al., 2016; Murphy et al., 2010; Wolk & Dickerson, 2011) and 
white matter disease (white matter hyperintensities (WMH) on brain MRI and CSF 
neurofilament light; Lee et al., 2016; Zetterberg et al., 2016). Second, we will test 
associations between the BFLT and other neuropsychological tests, hypothesizing 
BFLT indices will correlate most strongly with tests assessing verbal learning and 
memory (Benedict et al., 1996) and visuospatial and executive function (Jefferson et al., 
2006) but not language (Meyers & Meyers, 1995). Lastly, we provide regression-based 
normative data accounting for demographic variables that often confound cognitive 
performance including age, sex, race/ethnicity, and education (Glosser et al., 1989; 
Norman et al., 2000). These efforts will enhance the BFLT’s utilization as a more 
valuable tool in the assessment of visuospatial serial figure learning task in older adults. 
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Methods 
Participants 
Participant data were drawn from the Vanderbilt Memory & Aging Project 
(Jefferson et al., 2016), a longitudinal observational study investigating vascular health 
and unhealthy brain aging. Participants were recruited through postal mailings, radio 
advertisements, newsletters, research distribution emails, community events, websites, 
and word-of-mouth. Inclusion required participants be age 60 years or older, speak 
English, have adequate auditory and visual acuity for testing purposes, and have a 
reliable study partner defined as someone the participant has known for a minimum of 
two years, with weekly contact, and knowledge of the participant’s cognitive and 
functional abilities. At eligibility, participants underwent medical history and record 
review, clinical interview with the participant and their informant using the Clinical 
Dementia Rating (CDR; Morris, 1993) and Functional Activities Questionnaire (Pfeffer, 
Kurosaki, Harrah, Chance, & Filos, 1982), and a comprehensive neuropsychological 
protocol assessing multiple cognitive systems. Collectively, this information was used by 
a consensus team to determine each participant’s cognitive diagnosis, including:  
1. Cognitively normal participants (NC): defined as (a) CDR=0 (no dementia), (b) 
no deficits in activities of daily living directly attributable to cognitive 
impairment, and (c) no evidence of neuropsychological impairment defined as 
standard scores falling within 1.5 standard deviations of the age-adjusted 
normative mean.  
2. Early MCI: defined as (a) Clinical Dementia Rating (CDR)=0.5 (reflecting mild 
severity of impairment), (b) no deficits in activities of daily living attributable to 
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cognitive issues, and (c) no neuropsychological impairment defined as 
standard scores falling within 1.5 standard deviations of the age-adjusted 
normative mean (Aisen et al., 2010). 
3. MCI: defined as (a) CDR=0 or 0.5 (reflecting mild severity of impairment), (b) 
relatively spared activities of daily living, (c) neuropsychological impairment 
within at least one cognitive domain (i.e., performances falling greater than 
1.5 standard deviations outside the age-adjusted normative mean or pre-
morbid level of functioning), (d) concern of a cognitive change by the 
participant, informant, or clinician, and (e) absence of a dementing syndrome 
(Albert et al., 2011).  
Participants were excluded for a diagnosis other than normal cognition, early MCI, or 
MCI, history of neurological disease (e.g., dementia, multiple sclerosis, stroke), heart 
failure, major psychiatric illness, head injury with loss of consciousness >5 minutes, and 
systemic or terminal illness that could affect the individual’s ability to participate in 
follow-up examinations. Ultimately, this study enrolled 335 community-dwelling 
individuals age 60 to 92 years.  
 
Neuropsychological Assessment 
As part of the study enrollment visit, participants completed a neuropsychological 
protocol assessing multiple cognitive systems. Note, this protocol was different than 
what was used for eligibility determination and cognitive diagnosis at study entry. The 
BFLT methods are described in the introduction above and indices analyzed in the 
current study include: Trial 1 Learning, Trial 2 Learning, Trial 3 Learning, Trial 4 
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Learning, Trial 5 Learning, Trial 1-5 Total Learning, Distractor Trial (Trial B), Short Delay 
Free Recall, Long Delay Free Recall (following a 20 minute filled delay), Long Delay 
Recognition Measures (including Recognition Total Correct, Distractor Trial False 
Alarms, Novel False Alarms, Total False Alarms, Long Delay Recognition Total 
Discrimination calculated as follows: ((Recognition Total Correct + 0.5)/16) – ((Total 
False Alarms + 0.5)/31)), Total Repetitions, and Total Intrusions. See Table 1 for a 
more detailed description of these indices and information regarding the remaining 
measures in the neuropsychological protocol. 
 
Brain MRI  
Participants were scanned at the Vanderbilt University Institute of Imaging 
Science on a 3T Philips Achieva system (Best, The Netherlands) with 8-channel 
SENSE reception (Pruessmann, Weiger, Scheidegger, & Boesiger, 1999). T1-weighted 
MPRAGE (isotropic spatial resolution=1mm) images were post-processed for tissue 
volume quantification using an established Multi-Atlas Segmentation (Asman & 
Landman, 2012). Specific regions of interest included hippocampal volume and inferior 
lateral ventricle volume measured within each hemisphere and then summed across 
hemispheres for a total volume. Intracranial volume was defined using voxel-based 
morphometry in SPM8 (http://www.fil.ion.ucl.ac.uk/spm/software/spm8/). T2-weighted 
fluid-attenuated inversion recovery (FLAIR) was acquired for quantification of WMH and 
post-processed using the Lesion Segmentation Tool toolbox for SPM8 (Schmidt et al., 
2012).  
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Cerebrospinal Fluid Acquisition 
A subset of individuals (82 participants) completed an optional morning fasting 
lumbar puncture. CSF was collected with polypropylene syringes using a Sprotte 25-
gauge spinal needle in the L3/L4 or L4/L5 intervertebral lumbar space. Samples were 
immediately mixed and centrifuged, and supernatants were aliquoted in 0.5mL 
polypropylene tubes and stored at -80°C. Samples were analyzed in batch using 
commercially available enzyme-linked immunosorbent assays (Fujirebio, Ghent, 
Belgium) to determine the levels of Aβ1-42 (INNOTEST® β-AMYLOID(1-42)), total tau 
(INNOTEST® hTAU), and tau phosphorylated at threonine 181 (p-tau; INNOTEST® 
PHOSPHO-TAU(181P)). Neurofilament Light (NFL) was measured using a commercially 
available ELISA (Uman Diagnostics). Processing was completed by board certified 
laboratory technicians who were blinded to clinical information (Palmqvist et al., 2014). 
Intra-assay CVs were <10%. 
 
Statistical Analysis 
Descriptive statistics for participant characteristics including age, sex, 
race/ethnicity, education, mood (assessed with Geriatric Depression Scale (GDS) total 
score; Yesavage et al., 1983), CSF levels, brain MRI variables, and neuropsychological 
performances (see Table 1 for a comprehensive list of measures) were calculated. To 
assess construct validity, linear regression related selected BFLT indices (Total 
Learning, Short Delay Recall, Long Delay Recall, Total Discrimination) to markers of 
unhealthy brain aging adjusting for age, sex, education, race/ethnicity, and diagnosis in 
the entire cohort. Specifically, we assessed amyloidosis (CSF AB42), neurodegeneration 
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(CSF tau, CSF p-tau, hippocampal volume, inferior lateral ventricle volume), and white 
matter disease (WMH, CSF NFL). WMH values were log-transformed due to non-
normal distributions. Models analyzing brain volume outcomes additionally adjusted for 
intracranial volume. Convergent and discriminant validity were assessed in the NC 
subsample using Spearman’s rank correlation coefficients to relate selected BFLT 
indices with other neuropsychological variables and GDS total score (see Table 1 for a 
comprehensive list of measures). Regression-based normative data of the above 
selected BFLT indices was generated from the NC subgroup using multiple regression 
analyses adjusting for age, sex, education, and race/ethnicity. The raw score on the 
selected BFLT indices were used as outcomes. Sex was coded as male=0, female=1 
and race/ethnicity was coded as White/Non-Hispanic=0, Non-White/Hispanic=1. Age 
and education in years were treated as continuous variables. Multi-collinearity was 
assessed by calculating variance inflation factors (VIFs) and residuals plots were 
visually inspected for goodness of fit. Intercepts, beta-coefficients, and the root-mean-
squared error for each model were presented for calculation of a predicted BFLT 
performance value using the following equation (see Equation 1):  
(1) Predicted score= β0 (intercept) + βage X age (actual age in years) + βsex X sex 
(0=male, 1=female) + βrace/ethnicity X race/ethnicity (0=White/Non-Hispanic, 
1=Non-White/Hispanic) + βeducation X education (years of education 
completed).  
To calculate a z-score normative value, the predicted score calculated in Equation 1 
was used within the following equation (see Equation 2; Shirk et al., 2011):  
(2) z-score = (observed score – predicted score)/root-mean-squared-error.  
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Significance was set a priori at p<0.05. All analyses were conducted using R 3.2.0 
(www.r-project.org).  
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Results 
Participant Characteristics 
 The entire cohort comprised 322 participants with an age range of 60 to 92 years 
(73±7) and an education range of 7 to 20 years (16±3). Approximately half (51%, 
n=174) of individuals had normal cognition, 41% were women and 87% self-declared as 
White/Non-Hispanic. Global cognition, as assessed by the Montreal Cognitive 
Assessment (MoCA), ranged 14 to 30 (25.4±3.3). Table 2 contains full details on 
participant characteristics, brain volumes, CSF levels, and neuropsychological 
performances. 
 Normative data analyses included only NC participants, representing a 
subsample of 174 individuals with an age range of 60 to 92 years (72±7) and 41% 
women. A majority of NC participants self-declared as White/Non-Hispanic (87%) with 
an education range of 10 to 20 years (16±3). MoCA scores ranged from 17 to 30 
(27.0±2.2). Please see Table 2 for full details on NC participant characteristics and 
Table 3 for neuropsychological performances.  
 
BFLT & Biomarkers of Brain Health 
Amyloidosis: None of the examined BFLT indices were associated with CSF Aβ42 
values (all p-values>0.05; see Table 4). 
Neurodegeneration: Worse performance on all BFLT indices related to CSF 
markers of neurodegeneration, including higher t-tau (p-values<0.01) and p-tau levels 
(p-values<0.02). Similarly, lower scores on all BFLT variables related to smaller total 
hippocampal volume (p-values<0.01), smaller left hippocampal volume (p-
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values<0.001), larger total inferior lateral ventricle volume (p-values<0.05), and larger 
left inferior lateral ventricle volume (p-values<0.03). Only BFLT Short Delay Free Recall 
and Long Delay Free Recall were positively associated with right hippocampal volume 
(p-values<0.03). Only BFLT Long Delay Free Recall and Long Delay Total 
Discrimination were negatively associated with right inferior lateral ventricle volume (p-
values<0.05; see Table 4).  
White Matter Disease: None of the BFLT indices were related to WMH volume 
(all p-values>0.12; see Table 4).  
 
BFLT Correlations with Other Cognitive Measures 
Global Cognition: MoCA performance was moderately correlated with all BFLT 
indices (all p-values<0.001, see Table 5). 
Verbal Learning & Memory: CVLT-II Total Learning, Short Delay Free Recall, 
Long Delay Free Recall, and Recognition Total Discrimination correlated with all 
selected BFLT indices (p-values<0.001; see Table 5). CVLT-II Distractor Trial was 
correlated with most BFLT indices (p<0.02; see Table 5) but was unrelated to BFLT 
Recognition Total Discrimination (p=0.09; see Table 5).  
Visuospatial Learning & Memory: BVRT Total Score correlated with all selected 
BFLT indices (p-values<0.002; see Table 5). 
Visuospatial Abilities: Wechsler Adult Intelligence Scale-IV (WAIS-IV; Wechsler, 
2008) Block Design correlated with most BFLT indices (p-values<0.001) but not BFLT 
Distractor Trial (Trial B; p=0.08; see Table 5). Hooper Visual Organization Test 
(Hooper, 1983) performance was related to all selected BFLT indices (p-values<0.001). 
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See Table 5 for full details.  
Language: Both Boston Naming Test (30-item) performance (p-values<0.006) 
and Category Fluency performance (p-values<0.004) were correlated with all BFLT 
indices. See Table 5 for full details.  
Attention/Information Processing Speed: Delis Kaplan Executive Functioning 
System (DKEFS; Delis, Kaplan, & Kramer, 2001) Number Sequencing Test was related 
to most BFLT indices (p-values<0.001) except for BFLT Distractor Trial (p=0.05; see 
Table 5 for details). WAIS-IV Coding performance related to all BFLT indices (all p-
values<0.001; see Table 5 for details).  
Executive Functioning: DKEFS Tower Test performance was related to all BFLT 
indices (p-values<0.03; see Table 5). DKEFS Color-Word Interference Test Inhibition 
performance was related to most BFLT indices (p-values<0.02) except BFLT 
Recognition Total Discrimination (p=0.09; Table 5). DKEFS Number-Letter Switching 
Test and Letter Fluency were correlated with all BFLT indices (all p-values<0.001). See 
Table 5 for full details.  
Mood: GDS was unrelated to all BFLT indices (all p-values>0.37). See Table 5 
for details.  
 
BFLT Regression-Based Normative Data 
Review of VIF revealed no multicollinearity between predictor and demographic 
variables (all VIF<1.11). The residual plots against predicted values did not reveal any 
systematic patterns, suggesting sufficient goodness of fit. Means, intercepts, and 
regression coefficients are presented in Table 6 for transforming raw scores into 
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demographically adjusted z-scores using Equations 1 and 2 in the Statistical Analysis 
section.  
For illustrative purposes, normative data for BFLT Total Learning is calculated for 
an individual with the following demographics: 75 year old female, White/Non-Hispanic, 
with 16 years of education with a BFLT Total Learning score of 130. Using Equation 1, 
the predicted score is calculated as follows:  
223.7 (BFLT Total Learning intercept) + -1.79x75 (BFLT Total Learning βage X 
actual age) + 12.78x1 (BFLT Total Learning βsex X 0=male) + -10.30x0 (BFLT 
Total Learning βrace/ethnicity X 0=White/non-Hispanic) + 2.26x16 (BFLT Total 
Learning βeducation X # years of education completed) = predicted score of 138.39.   
To calculate a normative value with an obtained score of 130, Equation 2 is used:  
130 (observed score) – 138.39 (predicted score)/27.25 (root-mean-squared-error 
for BFLT Total Learning) = z-score of -0.31.  
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Discussion 
 The BFLT is a visuospatial serial figure-learning test that allows for 
comprehensive assessment of visual learning and memory and offers advantages to 
existing visual memory tests. This study aimed to improve the clinical utility of the BFLT 
among older adults by demonstrating the test’s psychometric properties, including 
validity. Specifically, BFLT performances were broadly related to CSF tau and medial 
temporal lobe brain volumes, but minimal associations with CSF amyloid or markers of 
white matter disease (WMH or CSF NFL) were observed. Furthermore, compared to 
other neuropsychological tests, BFLT indices correlated with measures of verbal 
learning and memory, information processing, executive functioning, and visuospatial 
performances, as expected. BFLT was also (unexpectedly) related to language tests. 
To further maximize the measure’s usefulness, regression-based normative data is 
provided with adjustments for common demographic confounds. 
The current results suggest that performance on the BFLT is related to medial 
temporal lobe structures involved in successful learning and memory. These structures 
include the hippocampus and surrounding perirhinal areas critical for the formation of 
new memories (Fell et al., 2001). These regions have been linked with performance on 
verbal supraspan episodic memory tests (Wolk & Dickerson, 2011) and existing visual 
memory tests (Buffalo, Reber, & Squire, 1998). The current results are among the first 
to highlight the construct validity of the BFLT to measure integrity of learning and 
memory structures.  
In addition to structural evidence of neurodegeneration, the BFLT was associated 
with CSF tau, another marker of neurodegeneration, but not amyloidosis or white matter 
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disease. Early patterns of atrophy seen on brain MRI are most notable within the medial 
temporal lobe (Convit et al., 2000), including the hippocampus (Fox et al., 1996) and 
inferior lateral ventricles (Thompson et al., 2004) because this region is the first to be 
affected by AD pathology. Tau deposition begins in the entorhinal cortex, spreading to 
the hippocampus and surrounding medial temporal regions (Braak & Braak, 1991; 
Duyckaerts, Delatour, & Potier, 2009), resulting in axonal loss and neurodegeneration. 
Tau deposition levels and brain volume loss are thought to be closely related (Fjell et 
al., 2010) and represent disease or symptom severity (Blennow, 2004). Additionally, tau 
correlates with objective cognitive performance (Samgard et al., 2010), including 
episodic memory (Fjell et al., 2008), often more closely than markers of amyloidosis 
(Brier et al., 2016). Taken cumulatively, the BFLT may be an important tool to assess 
for underlying neurodegenerative disorders. 
 The stronger association between BFLT indices and regions within the left medial 
temporal lobe as compared to the right was somewhat unexpected given earlier work 
linking the right medial temporal lobe with BFLT performances in epilepsy or non-AD 
related amnestic syndromes (Glosser et al., 2002; Glosser et al., 1989). However, this 
discrepant finding may be related to differing methodology given the previous results did 
not include any neuroimaging analyses and focused on clinical presentation of epilepsy 
patients. The current finding highlights the importance of left medial temporal lobe 
integrity for visual memory tasks, an observation supported by a functional MRI study 
linking activation in the left hippocampus to visual memory (Ranganath, Cohen, Dam, & 
D'Esposito, 2004). Alternatively, the right hippocampus may be integral in 
encoding/recalling information regarding spatial navigation or location (Burgess, 
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Maguire, & O'Keefe, 2002; Kesner, Bolland, & Dakis, 1993), a component of 
visuospatial memory and processing that is less essential to successful BFLT 
performance. Notably, the current findings suggest bilateral hippocampal integrity for 
retrieval of visual information, consistent with a recent meta-analysis implicating both 
the right and left hippocampus in retrieval of visual information (Lepage, Habib, & 
Tulving, 1998). The preferential association with the left hemisphere in encoding visual 
information provides additional evidence that individuals often utilize verbal strategies to 
encode visual material, even non-meaningful visual information, thus employing left 
hemisphere regions.  
 Surprisingly, there was a paucity of associations between BFLT indices and 
white matter disease. These null associations were surprising given the link between 
white matter disease and verbal memory, including supraspan paradigms analogous to 
the BFLT (Kennedy & Raz, 2009). Also, BFLT performance was related to measures of 
information processing speed and executive functioning, cognitive domains that are 
often closely correlated with WMH burden (Madden, Bennett, & Song, 2009; Prins et al., 
2005). The null findings could be due to the inclusion of cognitively normal participants 
in the analyses as well as the low prevalence of cardiovascular disease across the 
entire sample.  
BFLT related to verbal memory and visuospatial performances as measured by 
other popular tools (Benton, 1974; Delis et al., 2000). Similarly, BFLT correlated with 
executive function performances, an expected finding given the executive demands of 
the BFLT and existing support linking visuospatial abilities with executive skills. Prior 
research has suggested that executive functions, such as the capability to monitor and 
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switch between the target and distractor set of stimuli and the ability to organize the 
geometric shapes into accurate designs, is important during visuospatial tasks 
(Jefferson et al., 2006; Libon et al., 1994). Unexpectedly, BFLT was related to language 
performances possibly because individuals with more intact language abilities utilize 
verbal cues or assign common object descriptions to the BFLT design stimuli as a tool 
for successfully remembering design details (Schacter, Cooper, & Delaney, 1990). This 
idea is supported by our finding that BFLT performance appeared preferentially related 
to left hemisphere medial temporal lobe functioning and suggesting that successful 
performance on BFLT indices relies on integrity of brain regions also important for 
language abilities.  
Advancing age was noted to be related to poorer performance on all BFLT 
indices, consistent with previously research linking increasing age with declines in 
verbal memory (Gunning-Dixon & Raz, 2003; Norman et al., 2000) and visual retention 
(Coman et al., 1999). Sex, race/ethnicity, and education were inconsistently related to 
the various BFLT indices, although results are aligned with previous research 
suggesting better cognitive performance is related to more years of education, female 
sex, and White/non-Hispanic ethnicity. Given these potential demographic confounds on 
task performance, the regression-based normative data provided here incorporate all of 
these demographic factors, allowing for more robust generation of normative data. 
Additionally, the sample size of 174 well-characterized, cognitively normal, adults age 
60 to 92 represents an improvement to the existing normative data, facilitating more 
widespread clinical use of the BFLT.  
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The current study has several strengths. First, the extensive phenotyping of 
cognitive status for all enrolled participants included a CDR interview with the participant 
and a reliable informant, medical record and health history review, comprehensive 
neuropsychological protocol, and consensus decision for diagnostic status by 
experienced clinicians. Second, the comprehensive neuropsychological protocol 
examined in the current methods (which was separate from the protocol used to 
diagnose and enroll participants as NC) encompassed multiple cognitive domains, 
permitting detailed comparisons between BFLT and other cognitive task performances. 
Third, the normative sample size of the current study (n=174) and use of regression 
norms considering multiple demographic confounders enhances the one existing BFLT 
normative data report (Glosser et al., 2002). Fourth, the correlation data with other 
common neuropsychological tests, including an analogous verbal supraspan test, also 
provide context for interpreting underlying BFLT impairments in a comprehensive 
clinical evaluation. Lastly, this study is the first linking the BFLT to biological markers of 
brain health to assess the measure’s validity.  
Despite these strengths, there are several limitations. First, aspects of the cohort 
could limit the generalizability to the findings. For example, the sample is predominantly 
White with a mean college education level. Similarly, the inclusion and exclusion criteria 
associated with enrollment into the Vanderbilt Memory & Aging Project, including 
minimal cardiovascular disease, may limit generalized applicability. Second, the current 
study includes a smaller sample size in comparison to previous normative research with 
other learning and memory tests (Fine, Kramer, Lui, Yaffe, & Study Of Osteoporotic 
Fractures Sof Research, 2012; Gallassi et al., 2014). However, regression-based 
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normative procedures require smaller samples sizes than traditional-based normative 
procedures (Oosterhuis, van der Ark, & Sijtsma, 2016), and this study represents an 
initial and more comprehensive approach.  
Overall, our findings provide novel information about the BFLT to enhance the 
clinical utility of this visuospatial serial figure learning test. The BFLT measures brain 
health and integrity through the assessment of multiple aspects of learning and 
memory, including learning or rate of acquisition, encoding or storage, retrieval, 
recognition, and freedom from interference. Results suggest the BFLT has good 
psychometric properties and relates to medial temporal lobe integrity. Regression-based 
normative data based upon age, sex, education, and race/ethnicity are provided to 
enhance clinical utility of this promising visuospatial memory test. Further work is 
needed linking BFLT performance to longitudinal change in markers of pathology. 
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Table 1.  Neuropsychological Protocol 
Domain Test Description Range 
Global 
Cognition 
Montreal Cognitive Assessment 
(Nasreddine et al., 2005) 
Measures global cognitive status 0-30 
Episodic 
Learning & 
Memory 
Biber Figure Learning Test (BFLT; Glosser 
et al., 2002; Glosser et al., 1989) 
  
BFLT Total Learning (Trials 1-5) Assesses learning for a set of 15 geometric 
designs across 5 trials 
0-45 
BFLT Distractor Trial (Trial B) Assesses interference of learning a similar, 
novel set of 15 geometric designs 
0-45 
BFLT Short Delay Free Recall Assesses immediate free recall for a set of 15 
geometric designs following 5 learning trials and 
presentation of a 15-item distractor trial (without 
re-exposure to the original 15 test items) 
0-45 
BFLT Long Delay Free Recall Assesses delayed recall for a set of 15 
geometric designs following a 20-minute filled 
delay 
0-45 
BFLT Long Delay Recognition Total 
Correct 
Total number of correctly recognized geometric 
designs following a 20-minute filled delay 
0-15 
BFLT Long Delay Recognition Distractor 
Trial False Alarms 
Number of Distractor Trial geometric designs 
endorsed following a 20-minute filled delay 
0-7 
BFLT Long Delay Recognition Novel 
False Alarms 
Number of novel geometric designs endorsed 
following a 20-minute filled delay 
0-23 
BFLT Long Delay Recognition Total False 
Alarms 
Total number of non-target geometric designs 
recognized following a 20-minute filled delay 
0-30 
BFLT Long Delay Recognition Total 
Discrimination  
Assesses ability to discriminate the list of 15 
geometric designs from Distractor and non-
target designs after a 20-minute filled delay 
using the following formula: ((Recognition Total 
Correct + 0.5)/16))- ((Total False Alarms + 
0.5)/31)) 
-30-15 
   Biber Figure Learning Test 
 
35 
 
BFLT Repetitions Total number of geometric designs repeated 
during Total Learning (Trials 1-5), Distractor 
Trial, Short Delay Recall, Long Delay Recall 
n/a 
BFLT Intrusions Total number of non-target geometric designs 
endorsed during Total Learning (Trials 1-5), 
Distractor Trial, Short Delay Recall, Long Delay 
Recall 
n/a 
California Verbal Learning Test-II (CVLT-II; 
Delis et al., 2000) 
  
CVLT-II Total Learning (Trials 1-5) Assesses learning for a list of 16 words across 
5 trials 
0-16 
CVLT-II Distractor Trial Assesses interference of learning a similar, 
novel list of 16 words 
0-16 
CVLT-II Short Delay Free Recall Assesses short delay free recall for a list of 16 
words following 5 learning trials and 
presentation of a 16-item distractor trial (without 
re-exposure to the original 16 test items) 
0-16 
CVLT-II Long Delay Free Recall Assesses delayed free recall for a list of 16 
words after a 20-minute filled delay 
0-16 
CVLT-II Recognition Total Discrimination  Assesses ability to recognize the list of 16 
words from related and non-related non-target 
words after a 20-minute filled delay 
-4-4 
Benton Visual Retention Test 5th Edition 
(BVRT; Benton, 1974) Administration A 
Form C* 
Assesses immediate visual memory for 10 
designs presented for 10 seconds before 
reproducing them 
0-10 
Visuospatial 
Skills 
Wechsler Adult Intelligence Scale-4th 
Edition Block Design (WAIS-IV; Wechsler, 
2008)* 
Assesses the ability to visuospatial organization 
and construction 
0-66 
Hooper Visual Organization Test (HVOT; 
Hooper, 1983) 
Measures proficiency of object recognition 0-30 
Language 
Boston Naming Test-30 Item (even items; 
Kaplan, Goodglass, & Weintraub, 1983)  
Assesses confrontation naming and lexical 
retrieval abilities 
0-30 
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Category Fluency (Animal Naming; 
Goodglass & Kaplan, 1983)  
Measures rapid word generation in 60 seconds 
based on a specified category 
n/a 
Information 
Processing 
DKEFS Trail Making Test Number 
Sequencing (Delis et al., 2001)† 
Measures visual-scanning and attention in a 
number sequencing task 
0-150 
WAIS-IV Coding (Wechsler, 2008) Speeded measure assessing psychomotor, 
attention and processing speed 
0-93 
Executive 
Functioning 
DKEFS Tower Test (Delis et al., 2001) Measures planning and problem solving abilities 0-30 
DKEFS Color-Word Interference Test 
Inhibition (Delis et al., 2001)† 
Measures inhibition involving suppression of an 
automatic response in favor of a novel response 
0-90 
DKEFS Trail Making Test Number-Letter 
Switching (Delis et al., 2001)† 
Measures sequencing and mental flexibility in a 
number and letter set-shifting task 
0-240 
Letter Fluency (Controlled Oral Word 
Association; Benton, Hamsher, & Sivan, 
1994) 
Measures rapid word generation based on a 
specified letter across three trials (F, A, and S), 
each lasting 60 seconds 
n/a 
Mood 
Geriatric Depression Scale (GDS)-30 Item 
(Yesavage et al., 1983) 
Assesses symptoms of depressed mood 0-30 
Estimated 
Pre-Morbid 
Intelligence 
Wide Range Achievement Test-3rd Edition 
(WRAT-3) Reading Subtest (Wilkinson, 
1993)* 
Measures reading for words with irregular 
sound-to-spelling correspondence  
0-57 
Note. *Measure administered at the eligibility visit. All other tests administered at enrollment visit. †Speeded test where 
time to completion is the outcome and higher score denotes worse performance. DKEFS= Delis Kaplan Executive 
Function System. 
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Table 2. Participant Characteristics 
 NC Early MCI MCI 
Combined 
Sample 
p-value 
Sample Size 174 27 131 332 -- 
Demographic Characteristics      
Age, years 72±7 73±6 73±8 73±7 0.66 
Sex, % female 41 26 44 41 0.24 
Race, % White/Non-Hispanic 87 85 85 86 0.88 
Education, years 16±3 16±3 15±3 16±3 <0.001*§ 
Biber Figure Learning Test Performances      
Trial 1 14.4±5.4 11.1±5.2 8.6±5.4 11.8±6.1 <0.001*‡§¶ 
Trial 2 24.4±6.8 18.4±7.1 14.2±6.9 19.9±8.4 <0.001*‡§¶ 
Trial 3 29.4±7.3 23.9±6.9 17.9±7.7 24.4±9.2 <0.001*‡§¶ 
Trial 4 32.5±7.3 27.2±6.2 19.8±8.3 27.1±9.7 <0.001*‡§¶ 
Trial 5 34.5±7.1 29.4±5.9 21.8±9.4 29.1±10.0 <0.001*‡§¶ 
Total Learning (Trials 1-5) 135±31 110±28 82±35 112±41 <0.001*‡§¶ 
Distractor Trial (Trial B) 11.7±5.8 8.9±4.8 7.3±4.8 9.7±5.7 <0.001*§ 
Short Delay Free Recall 31.2±8.1 26.3±6.2 17.6±9.8 25.4±10.8 <0.001*‡§¶ 
Long Delay Free Recall 32.5±7.6 28.0±6.6 19.1±9.9 26.8±10.6 <0.001*‡§¶ 
Long Delay Recognition- Hits 14.0±1.5 13.2±1.6 12.5±2.4 13.4±2.0 <0.001*‡§ 
Long Delay Recognition- Related False Alarms 0.9±1.3 1.2±1.3 2.3±1.6 1.5±1.6 <0.001*§¶ 
Long Delay Recognition- Unrelated False Alarms 1.2±1.9 2.5±2.7 4.5±3.7 2.6±3.2 <0.001*‡§¶ 
Long Delay Recognition- Total False Alarms 2.1±2.8 3.7±3.7 6.8±4.9 4.1±4.4 <0.001*§¶ 
Long Delay Recognition- Discrimination 0.8±0.2 0.7±0.2 0.6±0.2 0.7±0.2 <0.001*‡§¶ 
Total Repetitions 0.2±0.5 0.2±0.4 0.3±0.8 0.2±0.6 0.88 
Total Extraneous Responses 0.6±1.5 0.3±0.5 0.7±3.2 0.6±2.3 0.18 
Brain MRI Measures      
Right Hippocampal Volume, mm3 3875±437 3741±343 3613±468 3759±459 <0.001*§ 
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Left Hippocampal Volume, mm3 3537±425 3348±323 3243±467 3404±456 <0.001*§ 
Total Hippocampal Volume, mm3 7412±840 7089±629 6856±878 7163±879 <0.001*§ 
Right Inferior Lateral Ventricle Volume, mm3 807±439 964±652 1147±747 956±617 <0.001*§ 
Left Inferior Lateral Ventricle Volume, mm3 869±471 1011±615 1254±836 1034±675 <0.001*§ 
Total Inferior Lateral Ventricle Volume, mm3 1676±879 1974±1232 2401±1493 1990±1235 <0.001*§ 
Intracranial Volume, cm3 1377±142 1406±106 1380±150 1381±142 0.47 
Log White Matter Hyperintensity Volume 1.8±1.3 2.0±0.9 2.3±1.2 2.0±1.3 <0.001*§ 
Cerebrospinal Fluid Markers      
Amyloid-β42, pg/mL 757±230 817±282 620±234 713±246 0.001*§ 
Total-tau, pg/mL 373±175 429±125 505±289 427±228 0.011*§ 
Phosphorylated-tau, pg/mL 56±22 63±17 68±31 61±26 0.049* 
Neurofilament Light, pg/mL 936±453 1088±465 1253±718 1069±583 0.003*§ 
Note: Data presented as mean±standard deviation or frequencies; NC=cognitively normal control; MCI=mild cognitive 
impairment *p<0.05; ‡NC>early MCI; §NC>MCI; ¶early MCI>MCI 
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Table 3. Neuropsychological Performances in Cognitively Normal Participants   
 n=174 
Montreal Cognitive Assessment 27.0±2.2 
CVLT-II Total Learning (Trials 1-5) 46.9±9.4 
CVLT-II Distractor Trial 4.7±1.7 
CVLT-II Short Delay Free Recall 10.0±3.3 
CVLT-II Long Delay Free Recall 10.5±3.3 
CVLT-II Recognition Total Discrimination 3.0±0.7 
Benton Visual Retention Test-V Total Score 6.8±1.5 
Wechsler Adult Intelligence Scale-IV Block Design 34.7±10.4 
Hooper Visual Organization Test 25.3±2.5 
Boston Naming Test 30-item (even items) 27.9±2.0 
Category Fluency (Animals) 21.0±4.9 
DKEFS Trail Making Test Number Sequencing* 36±13 
Wechsler Adult Intelligence Scale-IV Coding 57±12 
DKEFS Tower Test 16.1±4.3 
DKEFS Color-Word Interference Test Inhibition* 60±14 
Letter Fluency (FAS) 42.9±11.4 
DKEFS Trail Making Test Number-Letter Switching* 87±34 
Geriatric Depression Scale 30-item 2.4±2.8 
Wide Range Assessment Test-3 Reading Subtest 51.3±4.3 
Note: CVLT-II=California Verbal Learning Test;  DKEFS=Delis Kaplan 
Executive Functioning System; *Higher score reflects worse performance 
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Table 4. Biber Figure Learning Test & Markers of Amyloid, Neurodegeneration, & White Matter Disease 
 
  
 
BFLT 
Total Learning 
BFLT 
Short Delay 
Free Recall 
BFLT 
Long Delay 
Free Recall 
BFLT 
Discrimination 
 B p-value B p-value B p-value B p-value 
CSF Aβ42 0.64 0.30 3.00 0.20 3.69 0.12 124.35 0.28 
CSF T-tau -1.44 0.01* -6.70 0.002* -7.84 <0.001* -450.13 <0.001* 
CSF P-tau -0.15 0.02* -0.70 0.005* -0.80 0.001* -43.31 <0.001* 
CSF NFL -3.03 0.03* -8.00 0.14 -6.85 0.22 -307.32 0.25 
Right Hippocampus Volume  1.07 0.10 5.39 0.03* 7.49 0.002* 152.90 0.18 
Left Hippocampus Volume 2.25 <0.001* 9.36 <0.001* 11.40 <0.001* 377.99 0.001* 
Total Hippocampal Volume  3.32 0.008* 14.75 0.001* 18.88 <0.001* 530.90 0.01* 
Right Inferior Lateral Ventricle Volume -1.41 0.14 -6.37 0.07 -7.19 0.05* -497.16 0.003* 
Left Inferior Lateral Ventricle Volume  
Volume 
-2.36 0.02* -8.36 0.03* -11.37 0.003* -596.07 <0.001* 
T tal Inferior Lateral Ventricle Volume -3.77 0.04* -14.73 0.03* -18.55 0.008* -1093.23 <0.001* 
WMH Volume -0.002 0.26 -0.01 0.46 -0.01 0.50 -0.54 0.12 
Note: BFLT=Biber Figure Learning Test; CSF= cerebrospinal fluid; Aβ=amyloid beta; T-tau=total tau; p-tau=phosphorylated 
tau; NFL=neurofilament light; WMH=white matter hyperintensity (log-transformed); *significance threshold at p-value<0.05. 
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Table 5.  Biber Figure Learning Test Correlations with Other Neuropsychological Measures  
 
  
 
BFLT 
Total Learning 
BFLT 
Short Delay 
Free Recall 
BFLT 
Long Delay 
Free Recall 
BFLT 
Discrimination 
 r p-value r p-value r p-value r p-value 
Montreal Cognitive Assessment 0.49 <0.001* 0.40 <0.001* 0.41 <0.001* 0.42 <0.001* 
CVLT-II Total Learning (Trials 1-5) 0.54 <0.001* 0.49 <0.001* 0.51 <0.001* 0.43 <0.001* 
CVLT-II Distractor Trial 0.26 <0.001* 0.30 <0.001* 0.22 0.004* 0.13 0.09 
CVLT-II Short Delay Free Recall 0.51 <0.001* 0.50 <0.001* 0.50 <0.001* 0.44 <0.001* 
CVLT-II Long Delay Free Recall 0.53 <0.001* 0.54 <0.001* 0.52 <0.001* 0.45 <0.001* 
CVLT-II Recognition Discrimination 0.36 <0.001* 0.37 <0.001* 0.36 <0.001* 0.34 <0.001* 
BVRT Total Score 0.41 <0.001* 0.44 <0.001* 0.44 <0.001* 0.24 0.002* 
WAIS-IV Block Design 0.33 <0.001* 0.32 <0.001* 0.34 <0.001* 0.36 <0.001* 
Hooper Visual Organization Test 0.38 <0.001* 0.41 <0.001* 0.31 <0.001* 0.29 <0.001* 
Boston Naming Test 30-Item 0.38 <0.001* 0.38 <0.001* 0.30 <0.001* 0.36 <0.001* 
Category Fluency (Animals) 0.32 <0.001* 0.37 <0.001* 0.31 <0.001* 0.28 <0.001* 
DKEFS Number Sequencing† -0.27 <0.001* -0.33 <0.001* -0.31 <0.001* -0.24 0.001* 
WAIS-IV Coding 0.41 <0.001* 0.42 <0.001* 0.40 <0.001* 0.26 <0.001* 
DKEFS Tower Test 0.25 <0.001* 0.23 0.002* 0.23 0.002* 0.18 0.02* 
DKEFS Color-Word Inhibition† -0.27 <0.001* -0.22 0.004* -0.18 0.02* -0.13 0.09 
DKEFS Number-Letter Switching† -0.28 <0.001* -0.31 <0.001* -0.30 <0.001* -0.26 <0.001* 
Letter Fluency (FAS) 0.41 <0.001* 0.37 <0.001* 0.28 <0.001* 0.36 <0.001* 
Geriatric Depression Scale 30-Item 0.07 0.37 0.06 0.47 0.04 0.58 -0.04 0.59 
Note: CVLT-II=California Verbal Learning Test-2nd Edition;  BVRT=Benton Visual Retention Test 5th Edition; WAIS-
IV=Wechsler Adult Intelligence Scale-4th Edition; DKEFS=Delis Kaplan Executive Functioning System, *significance 
threshold at p<0.01; †higher scores reflect worse performance 
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Table 6. Mean and Regression Coefficients for Normative Data Calculation  
 
 
Mean±SD Intercept β (age) β (sex) 
 β (race/ 
ethnicity) 
β 
(education) 
RMSE 
BFLT Total Learning (Trials 1-5) 135.0±31.0 223.7 -1.79*** 12.78** -10.30 2.26* 27.25 
BFLT Distractor Trial 11.7±5.8 21.6 -0.21*** 2.09* 1.68 0.23 5.49 
BFLT Short Delay Free Recall 31.2±8.1 59.9 -0.46*** 1.26 -4.75** 0.30 7.26 
BFLT Long Delay Free Recall 32.5±7.6 54.4 -0.40*** 1.11 -3.59* 0.45 6.96 
BFLT Recognition Discrimination 0.82±0.15 0.9 -0.004** 0.03 -0.08* 0.01** 0.14 
Note: *p<0.05, **p<0.01, ***p<0.001; RMSE=root mean square error 
